Europe's Generics Industry Takes Action To Maintain Medicines Access In Ukraine
Efforts are being made across the European off-patent community to bolster the supply chain and ensure access to medicines in Ukraine, says the generics and biosimilars industry association, Medicines for Europe. It has urged the EU to take a leading role in coordinating supplies through the new emergency response body, HERA.
You may also be interested in...
With the Shanghai lockdown extended, Russian vessels blacklisted and oil prices fluctuating, global freight rates are expected to increase further. Apart from a direct hit, pharma manufacturers will also feel the ripple effect as prices of raw materials like APIs increase. Scrip spoke to Indian industry to gauge the impact.
R&D-based pharma firms and European parallel traders are contributing to the emergency relief effort in Ukraine and to the refugee crisis by making financial donations to humanitarian organizations or sending medicines and other medical supplies directly to Ukraine.
Leading Indian firms with operations in the war zone stare at uncertainties and disruptions as sanctions by the US and Western allies threaten to choke the Russian economy.